DUBLIN--(BUSINESS WIRE)--The "Global Biological and Medical Imaging Reagent market (2017-2022)" report has been added to ResearchAndMarkets.com's offering.
The Global Biological and Medical Imaging Reagent market is expected to grow at a CAGR of 8% (2017-2022) to reach a global revenue of USD 11.22 billion by 2022.
Surge in demand for various image guided medical treatment procedure for minimum invasive surgeries is one of the most important factor anticipated to trigger the demand for various biological and medical imaging reagents during the forecast period from 2017-2022.
In addition, rapid research and development activities taking place in the field of drug discovery in order to manufacture advanced patient centric drug is also predicted to create a better opportunity for various biological and medical imaging reagent manufacturers in the coming years.
In-spite of so many factors that are anticipated to impact a positive growth on the global biological and medical imaging reagent market, healthcare reforms adopted by some of the major economies that resulted in declining reimbursement on various medical imaging examination is one of the most important factor that is expected to limit the demand of imaging technologies in the coming years, which in turn is anticipated to deter the growth rate of biological and medical imaging reagents during the forecast period.
Segments Analyzed
Depending on the various class of biological and medical imaging reagents available in the market, the market has been classified into contrast reagents, radiopharmeceuticals and optical reagents. Though the contrast reagent segment held the largest market share in 2016, the optical reagent segment is expected to experience the most promising demand in the coming years.
Extensive utilization of optical imaging reagents by various drug developer and life science researchers to detect and visualize various biological processes at the molecular level in order to perform proteomics, key genomics and cellular analysis assays for developing advanced categories of patient centric targeted drug is the most important factors behind this segment's rapid growth rate.
In addition, demand for biological and medical imaging reagents across various application segments including X-Ray, MRI (magnetic resonance imaging), PET/CT (positron emission tomography/computed tomography) and ultrasonography is also provided in this report.
Among the different application segments, demand for biological and medical imaging reagents from the X-Ray segment held the largest market share in 2016 owing to its increasing application across various medical treatments such as orthopedic damage, cardiovascular diseases (CVD), pneumonia, cancers / tumors and dental among others.
Moreover, based on the route of administration the global biological and medical imaging reagents has been categorized into intravascular through injection, oral and enema through rectal. Among the different route of administration, the imaging reagents administered through injection held the largest market share in 2016 and is also expected to witness the fastest growth during the forecast period.
Exponential growth in this segment is primarily attributed to the rapid advancements in PET, CT and MRI imaging technologies that majorly rely on the use of intravascular route to inject imaging reagents.
Furthermore, by end-use, the market has been bifurcated into utilization of imaging reagents in diagnostic, drug discover and research and development sectors. Being an integral part of various diagnostic application, the diagnosis sector generated the highest revenue in 2016 across various end-use sectors and is expected to maintain its revenue generation trend in the coming years.
Geographically, North America dominated the overall biological and medical imaging reagent market in 2016. However, large consumer base of imaging reagents on account of rising incident of chronic diseases coupled with increasing number of geriatric population is anticipated to turn Asia Pacific region into the most promising market for biological and medical imaging reagents.
In terms of competitive landscape, the market is consolidated in nature with the existence of few vendors. Some of the major players operating the Global Biological and Medical imaging Reagent market includes GE Healthcare (The U.K), Bayer AG (Germany), Guerbet (France) and Bracco S.p.A (Italy) among others.
Key Topics Covered
Chapter 1. Executive Summary
Chapter 2. Biological and Medical Imaging Reagents Market Overview
Chapter 3. Global Biological and Medical Imaging Reagent Market Analysis
Chapter 4. North America Biological and Medical Imaging Reagent Market Analysis
Chapter 5. Europe Biological and Medical Imaging Reagent Market Analysis
Chapter 6. Asia Pacific Biological and Medical Imaging Reagent Market Analysis
Chapter 7. Middle-East and Africa Biological and Medical Imaging Reagent Market Analysis
Chapter 8. Latin America Biological and Medical Imaging Reagent Market Analysis
Chapter 9. Company Profiles
- GE Healthcare
- Bayer AG
- Guerbet
- Bracco
- J. B. Chemicals and Pharmaceuticals Ltd.
- Unijules Life Sciences Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/ghdwbc/global_biological?w=4
